A technician’s guide to new and old oral anticoagulants
Technicians in community-based practice.
Universal program number: 0401-0000-16-206-H01-T
CE Broker tracking number: 20-583778
Activity type: Knowledge-based
To compare and contrast the role of new oral anticoagulants as compared with warfarin.
With four new oral anticoagulants approved over the last decade, patients have more treatment options for a number of conditions that were previously treated with warfarin. Community pharmacy technicians must be aware of how the new agents are commonly used, as well as the potential serious adverse effects that patients may experience, to assist the pharmacist in providing the best patient care and education. Additionally, because newer agents may present cost concerns for patients, a review of average costs of therapies will be discussed. This lesson will review these topics and provide an overview of clinical pearls that can be applied in practice.
Upon completion of this program, the technician should be able to:
- List common uses for oral anticoagulants.
- Identify adverse effects associated with oral anticoagulants.
- Recall cost differences among available anticoagulant therapies.
To obtain credit:
To complete the program and receive CPE credit, view all lesson content and complete the learning assessment by submitting answers online. A minimum test score of 70% is needed to obtain credit. After successfully completing the learning assessment, participants must complete a program evaluation and claim the available CPE credit. Participants also must verify personal information required by CPE monitor and/or CE Broker (for Florida license holders) prior to submitting CPE credit claims. Official statements of credit are available only through CPE Monitor located at NABP.net.
If you have a question, visit our Frequently Asked Questions page.
All other customer service questions should be directed to DRSNCE@lf1925.com.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for technicians and is worth 1.0 contact hours (0.1 CEUs). The activity is available for CE credit through Dec. 15, 2019.
Jon P. Wietholter, PharmD, BCPS, clinical associate professor, WVU School of Pharmacy, internal medicine clinical pharmacist, WVU-Medicine Ruby Memorial Hospital
Jon P. Wietholter and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 1.00 Technician